Pulse Biosciences to Present at Needham Healthcare Conference
Event summary
- Pulse Biosciences (Nasdaq: PLSE) will present at the 25th Annual Needham Virtual Healthcare Conference on April 16, 2026.
- Live and recorded webcast available via the company’s investor relations website.
- Focus on nPulse™ technology for atrial fibrillation and surgical soft tissue ablation.
The big picture
Pulse Biosciences’ participation in the Needham Healthcare Conference underscores its push to validate its proprietary nPulse™ technology in high-growth medical segments. The event provides a platform to showcase its non-thermal cell-clearing approach, which could disrupt traditional ablation methods if clinical and commercial adoption accelerates.
What we're watching
- Technology Validation
- How the presentation will position nPulse™ in the competitive landscape of atrial fibrillation treatments.
- Market Expansion
- Whether Pulse Biosciences can sustain momentum in surgical soft tissue ablation markets.
- Investor Sentiment
- The pace at which investor interest translates into tangible partnerships or funding rounds post-conference.
Related topics